BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11313809)

  • 1. Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.
    Fisher KD; Stallwood Y; Green NK; Ulbrich K; Mautner V; Seymour LW
    Gene Ther; 2001 Mar; 8(5):341-8. PubMed ID: 11313809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
    Green NK; Morrison J; Hale S; Briggs SS; Stevenson M; Subr V; Ulbrich K; Chandler L; Mautner V; Seymour LW; Fisher KD
    J Gene Med; 2008 Mar; 10(3):280-9. PubMed ID: 18214996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.
    Ogawara K; Rots MG; Kok RJ; Moorlag HE; Van Loenen AM; Meijer DK; Haisma HJ; Molema G
    Hum Gene Ther; 2004 May; 15(5):433-43. PubMed ID: 15144574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
    Morrison J; Briggs SS; Green N; Fisher K; Subr V; Ulbrich K; Kehoe S; Seymour LW
    Mol Ther; 2008 Feb; 16(2):244-51. PubMed ID: 18071336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
    Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
    Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins.
    Stevenson M; Hale AB; Hale SJ; Green NK; Black G; Fisher KD; Ulbrich K; Fabra A; Seymour LW
    Cancer Gene Ther; 2007 Apr; 14(4):335-45. PubMed ID: 17235355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells.
    Stevenson M; Boos E; Herbert C; Hale A; Green N; Lyons M; Chandler L; Ulbrich K; van Rooijen N; Mautner V; Fisher K; Seymour L
    Gene Ther; 2006 Feb; 13(4):356-68. PubMed ID: 16355117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced gene transfer activity of peptide-targeted gene-delivery vectors.
    Parker AL; Fisher KD; Oupicky D; Read ML; Nicklin SA; Baker AH; Seymour LW
    J Drug Target; 2005 Jan; 13(1):39-51. PubMed ID: 15848953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy.
    Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC
    J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.
    Gu DL; Gonzalez AM; Printz MA; Doukas J; Ying W; D'Andrea M; Hoganson DK; Curiel DT; Douglas JT; Sosnowski BA; Baird A; Aukerman SL; Pierce GF
    Cancer Res; 1999 Jun; 59(11):2608-14. PubMed ID: 10363982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand.
    Hoganson DK; Sosnowski BA; Pierce GF; Doukas J
    Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPMA copolymers for masking and retargeting of therapeutic viruses.
    Fisher KD; Seymour LW
    Adv Drug Deliv Rev; 2010 Feb; 62(2):240-5. PubMed ID: 20005911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors.
    Wesseling JG; Bosma PJ; Krasnykh V; Kashentseva EA; Blackwell JL; Reynolds PN; Li H; Parameshwar M; Vickers SM; Jaffee EM; Huibregtse K; Curiel DT; Dmitriev I
    Gene Ther; 2001 Jul; 8(13):969-76. PubMed ID: 11438831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer.
    Morrison J; Briggs SS; Green NK; Thoma C; Fisher KD; Kehoe S; Seymour LW
    Hum Gene Ther; 2009 Mar; 20(3):239-51. PubMed ID: 19257852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
    Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
    Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells.
    Bachtarzi H; Stevenson M; Subr V; Seymour LW; Fisher KD
    J Drug Target; 2011 Sep; 19(8):690-700. PubMed ID: 21309681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.
    Li HJ; Everts M; Yamamoto M; Curiel DT; Herschman HR
    Cancer Res; 2009 Jan; 69(2):554-64. PubMed ID: 19147569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera.
    Carlisle RC; Benjamin R; Briggs SS; Sumner-Jones S; McIntosh J; Gill D; Hyde S; Nathwani A; Subr V; Ulbrich K; Seymour LW; Fisher KD
    J Gene Med; 2008 Apr; 10(4):400-11. PubMed ID: 18220318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted adenovirus vectors.
    Mizuguchi H; Hayakawa T
    Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.